基于前脑啡肽的肾小球滤过率评估方程
在国际多中心1354例稳定和危重患者中,以iohexol或iothalamate清除率测得mGFR,开发并验证基于PENK的eGFR方程。验证集显示PENK方程偏差0.5 ± 15 ml/min per 1.73 m2,P30准确率83%,优于MDRD和2009 CKD-EPI,与2021 CKD-EPI无显著差异。
要点
- PENK基方程偏差0.5 ± 15 ml/min per 1.73 m2,显著低于MDRD和2009 CKD-EPI。
- PENK基方程P30准确率83%,显著高于MDRD(68%)和2009 CKD-EPI(76%)。
- 与2021 CKD-EPI相比,PENK基方程偏差和P30准确率均无显著差异。
核心结论
- 基于PENK的eGFR方程在不使用性别或种族的情况下,性能优于大多数基于肌酐的方程。
研究设计与样本
- 国际多中心研究,纳入1354例稳定和危重患者,通过iohexol或iothalamate清除率测量mGFR。
- 采用广义线性模型(S形非线性传递函数)在区组随机化开发集中开发方程,协变量以数据驱动方式选择。
- 在验证集中评估新方程的偏差、精确度(均值±SD)和准确度(eGFR在mGFR±30%内的百分比,P30),并与MDRD和CKD-EPI比较。
主要发现
- 中位mGFR为61 [44-81] ml/min per 1.73 m2。
- PENK、肌酐和年龄按重要性依次纳入方程,性别或种族未改善性能。
- PENK基方程平均偏差0.5 ± 15 ml/min per 1.73 m2,显著低于MDRD(8 ± 17,P < 0.001)和2009 CKD-EPI(5 ± 17,P < 0.001),与2021 CKD-EPI(1.3 ± 16,P = 0.06)无统计学显著差异。
- PENK基方程P30准确率83%,显著高于MDRD(68%,P < 0.001)和2009 CKD-EPI(76%,P < 0.001),与2021 CKD-EPI(80%,P = 0.13)相似。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In clinical practice, kidney (dys)function is monitored through creatinine-based estimations of glomerular filtration rate (eGFR: Modification of Diet in Renal Disease [MDRD], Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI]). Creatinine is recognized as a late and insensitive biomarker of glomerular filtration rate (GFR). The novel biomarker proenkephalin (PENK) may overcome these limitations, but no PENK-based equation for eGFR is currently available. Therefore, we developed and validated a PENK-based equation to assess GFR. METHODS: In this international multicenter study in 1354 stable and critically ill patients, GFR was measured (mGFR) through iohexol or iothalamate clearance. A generalized linear model with sigmoidal nonlinear transfer function was used for equation development in the block-randomized development set. Covariates were selected in a data-driven fashion. The novel equation was assessed for bias, precision (mean ± SD), and accuracy (eGFR percentage within ±30% of mGFR, P30) in the validation set and compared with MDRD and CKD-EPI. RESULTS: Median mGFR was 61 [44-81] ml/min per 1.73 m2. In order of importance, PENK, creatinine, and age were included, and sex or race did not improve performance. The PENK-based equation mean ± SD bias of the mGFR was 0.5 ± 15 ml/min per 1.73 m2, significantly less compared with MDRD (8 ± 17, P < 0.001) and 2009 CKD-EPI (5 ± 17, P < 0.001), not reaching statistical significance compared with 2021 CKD-EPI (1.3 ± 16, P = 0.06). The P30 accuracy of the PENK-based equation was 83%, significantly higher compared with MDRD (68%, P < 0.001) and 2009 CKD-EPI (76%, P < 0.001), similar to 2021 CKD-EPI (80%, P = 0.13). CONCLUSION: Overall, the PENK-based equation to assess eGFR performed better than most creatinine-based equations without using sex or race.
引用
- Beunders R, Donato LJ, van Groenendael R, et al. Assessing GFR With Proenkephalin. Kidney Int Rep. 2023. PMID: 38025210. doi:10.1016/j.ekir.2023.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。